FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022473652> ?p ?o ?g. }

• W2022473652 endingPage "42" @default.
• W2022473652 startingPage "39" @default.
• W2022473652 abstract "Gamma-linolenic acid (GLA) is known to be cytotoxic to malignant cells. We assessed the efficacy of the novel intravesical formulation, meglumine gamma-linolenic acid (MeGLA), in a phase II trial, in patients with recurrent, superficial bladder cancer.Thirty patients with recurrent, superficial transitional cell carcinoma (TCC) were recruited. The tumour pattern was recorded at flexible cystoscopy. Patients received a single intravesical instillation of 50ml of either 50mg (1mg/ml) (15 patients), or 125mg (2.5mg/ml) (15 patients) of MeGLA in water, retained for one hour. At subsequent cystoscopy, the tumour patterns were recorded, prior to undertaking routine cystodiathermy. Biopsies were obtained for histological assessment. Responses were divided into complete, partial or none.All 30 patients retained the drug for 1 hour without significant local or systemic side effects. There were 4 (13%) complete responses, 9 (30%) partial responses, and 17 (57%) non-responders. Histology showed no evidence of damage to surrounding urothelium.Our data confirms the safety and tolerability of MeGLA, which is consistent with findings from a previous phase I trial. A response rate of 43% also indicates that MeGLA has a significant cytotoxic effect against TCC and the results are similar to those obtained using standard, single-dose, intravesical regimens." @default.
• W2022473652 created "2016-06-24" @default.
• W2022473652 creator A5005984728 @default.
• W2022473652 creator A5008229289 @default.
• W2022473652 creator A5021728701 @default.
• W2022473652 creator A5040956604 @default.
• W2022473652 creator A5041334197 @default.
• W2022473652 creator A5073653615 @default.
• W2022473652 creator A5073807713 @default.
• W2022473652 date "2002-07-01" @default.
• W2022473652 modified "2023-10-14" @default.
• W2022473652 title "Intravesical Meglumine Gamma-Linolenic Acid in Superficial Bladder Cancer: An Efficacy Study" @default.
• W2022473652 cites W148459091 @default.
• W2022473652 cites W1547892722 @default.
• W2022473652 cites W1575044740 @default.
• W2022473652 cites W181395934 @default.
• W2022473652 cites W1973547924 @default.
• W2022473652 cites W1999941850 @default.
• W2022473652 cites W2002666279 @default.
• W2022473652 cites W2010318650 @default.
• W2022473652 cites W2016233738 @default.
• W2022473652 cites W2032884409 @default.
• W2022473652 cites W2064946335 @default.
• W2022473652 cites W2073609832 @default.
• W2022473652 cites W2082240886 @default.
• W2022473652 cites W2089541850 @default.
• W2022473652 cites W2091163869 @default.
• W2022473652 cites W2123587341 @default.
• W2022473652 cites W2123614023 @default.
• W2022473652 cites W2126747820 @default.
• W2022473652 cites W2147213688 @default.
• W2022473652 cites W2174771007 @default.
• W2022473652 cites W2185643644 @default.
• W2022473652 cites W2412149065 @default.
• W2022473652 cites W2414445522 @default.
• W2022473652 cites W2415656871 @default.
• W2022473652 cites W321129 @default.
• W2022473652 doi "https://doi.org/10.1016/s0302-2838(02)00208-7" @default.
• W2022473652 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12121728" @default.
• W2022473652 hasPublicationYear "2002" @default.
• W2022473652 type Work @default.
• W2022473652 sameAs 2022473652 @default.
• W2022473652 citedByCount "16" @default.
• W2022473652 countsByYear W20224736522013 @default.
• W2022473652 crossrefType "journal-article" @default.
• W2022473652 hasAuthorship W2022473652A5005984728 @default.
• W2022473652 hasAuthorship W2022473652A5008229289 @default.
• W2022473652 hasAuthorship W2022473652A5021728701 @default.
• W2022473652 hasAuthorship W2022473652A5040956604 @default.
• W2022473652 hasAuthorship W2022473652A5041334197 @default.
• W2022473652 hasAuthorship W2022473652A5073653615 @default.
• W2022473652 hasAuthorship W2022473652A5073807713 @default.
• W2022473652 hasConcept C121608353 @default.
• W2022473652 hasConcept C126322002 @default.
• W2022473652 hasConcept C126894567 @default.
• W2022473652 hasConcept C141071460 @default.
• W2022473652 hasConcept C178790620 @default.
• W2022473652 hasConcept C185592680 @default.
• W2022473652 hasConcept C19038510 @default.
• W2022473652 hasConcept C197934379 @default.
• W2022473652 hasConcept C2777540882 @default.
• W2022473652 hasConcept C2778065480 @default.
• W2022473652 hasConcept C2778375690 @default.
• W2022473652 hasConcept C2778769751 @default.
• W2022473652 hasConcept C2779311130 @default.
• W2022473652 hasConcept C2779762690 @default.
• W2022473652 hasConcept C2780352672 @default.
• W2022473652 hasConcept C543025807 @default.
• W2022473652 hasConcept C71924100 @default.
• W2022473652 hasConcept C77411442 @default.
• W2022473652 hasConcept C90924648 @default.
• W2022473652 hasConceptScore W2022473652C121608353 @default.
• W2022473652 hasConceptScore W2022473652C126322002 @default.
• W2022473652 hasConceptScore W2022473652C126894567 @default.
• W2022473652 hasConceptScore W2022473652C141071460 @default.
• W2022473652 hasConceptScore W2022473652C178790620 @default.
• W2022473652 hasConceptScore W2022473652C185592680 @default.
• W2022473652 hasConceptScore W2022473652C19038510 @default.
• W2022473652 hasConceptScore W2022473652C197934379 @default.
• W2022473652 hasConceptScore W2022473652C2777540882 @default.
• W2022473652 hasConceptScore W2022473652C2778065480 @default.
• W2022473652 hasConceptScore W2022473652C2778375690 @default.
• W2022473652 hasConceptScore W2022473652C2778769751 @default.
• W2022473652 hasConceptScore W2022473652C2779311130 @default.
• W2022473652 hasConceptScore W2022473652C2779762690 @default.
• W2022473652 hasConceptScore W2022473652C2780352672 @default.
• W2022473652 hasConceptScore W2022473652C543025807 @default.
• W2022473652 hasConceptScore W2022473652C71924100 @default.
• W2022473652 hasConceptScore W2022473652C77411442 @default.
• W2022473652 hasConceptScore W2022473652C90924648 @default.
• W2022473652 hasIssue "1" @default.
• W2022473652 hasLocation W20224736521 @default.
• W2022473652 hasLocation W20224736522 @default.
• W2022473652 hasOpenAccess W2022473652 @default.
• W2022473652 hasPrimaryLocation W20224736521 @default.
• W2022473652 hasRelatedWork W1036257620 @default.
• W2022473652 hasRelatedWork W1976830962 @default.
• W2022473652 hasRelatedWork W2001372715 @default.

• next